federal_register: 2025-09757
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts | regulation_id_numbers |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09757 | Request for Comments Regarding Foreign Nations Freeloading on American-Financed Innovation | Notice | Pursuant to the Executive Order titled Delivering Most- Favored-Nation Prescription Drug Pricing to American Patients, USTR invites comments from interested parties regarding any act, policy, or practice that may be unreasonable or discriminatory and that has the effect of forcing American patients to pay for a disproportionate amount of global pharmaceutical research and development, including by suppressing the price of pharmaceutical products below fair market value in foreign countries. | 2025-05-30 | 2025 | 5 | https://www.federalregister.gov/documents/2025/05/30/2025-09757/request-for-comments-regarding-foreign-nations-freeloading-on-american-financed-innovation | https://www.govinfo.gov/content/pkg/FR-2025-05-30/pdf/2025-09757.pdf | Trade Representative, Office of United States | 491 | Pursuant to the Executive Order titled Delivering Most- Favored-Nation Prescription Drug Pricing to American Patients, USTR invites comments from interested parties regarding any act, policy, or practice that may be unreasonable or discriminatory and... |